News
Optimus Pharma gets nod from DGCI to make COVID-19 drug ‘Favicovid’
Optimus Pharma said it has received the Drugs Controller General of India (DCGI) approval to manufacture and market Favipiravir 200 mg tablets for the treatment...
Drug Research
Seven Indian Drugmakers Race To Develop Covid-19 Vaccine
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E among domestic pharma firms working on the vaccines in India
At least...
News
Dm-drogerie markt opens a new distribution center in Germany: with robotics & software from Swisslog
The first pallet leaving the center in Wustermark headed for our dm drugstores marks a milestone,” said Christoph Werner, Chairman of the dm Board, in...
Clinical Trials
Lilly’s Mirikizumab Superior to Cosentyx in a Phase 3 Study for Patients with Moderate to Severe Plaque Psoriasis
Eli Lilly and Company announced that mirikizumab, an investigational monoclonal antibody that binds to the p19-subunit of IL23, met the primary and all key secondary...
News
Merck, contract research firm IRBM partner on coronavirus therapies
Merck (MSD) has collaborated with contract research services company IRBM for the identification and development of new peptide therapeutics that can target various strains of...
News
Gilead Sciences to Acquire Tizona Therapeutics for $300 Million
Gilead Sciences, Inc. announced that it will invest $300 million to acquire a 49.9 percent equity interest in Tizona Therapeutics, Inc., a privately held company...
Clinical Trials
SGS to provide analytical testing for AstraZenecas Covid-19 vaccine
SGS will provide its services to support the development of AstraZeneca’s Covid-19 vaccine candidate – AZD1222 – which was co-invented by the University of Oxford...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.